LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer. Zhan L, Zhang J, Zhang J, Liu X, et al. Cancer Lett 2021;529:37-52.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhan L, Zhang J, Zhang J, Liu X, et al. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer. Cancer Lett 2021;529:37-52.
PMID: 34974132